General Information of This Payload
Payload ID
PAY0KQMZL
Name
CP1422
Synonyms
CP1422
   Click to Show/Hide
Structure
Formula
C30H32FN5O7
Isosmiles
CN(COCC(N[C@H]1CCC2=C3C1=C4CN(C(C4=NC3=CC(F)=C2C)=C5)C(C(CO6)=C5[C@](CC)(O)C6=O)=O)=O)C(CN)=O
PubChem CID
171825206
InChI
InChI=1S/C30H32FN5O7/c1-4-30(41)18-7-22-27-16(10-36(22)28(39)17(18)11-43-29(30)40)26-20(33-23(37)12-42-13-35(3)24(38)9-32)6-5-15-14(2)19(31)8-21(34-27)25(15)26/h7-8,20,41H,4-6,9-13,32H2,1-3H3,(H,33,37)/t20-,30-/m0/s1
InChIKey
AHKQURCPZLTMLU-WRGVRERRSA-N
Pharmaceutical Properties
Molecule Weight
593.612
Polar area
166.08
Complexity
1732.554234
xlogp Value
1.02182
Heavy Count
43
Rot Bonds
7
Hbond acc
10
Hbond Donor
3
Each Antibody-drug Conjugate Related to This Payload
Full Information of The Activity Data of The ADC(s) Related to This Payload
aHer2- (AL7-LP9)n [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
0.14 nM
High HER2 expression (HER2 +++)
Method Description
The cell line used in the anti-proliferation assays was SK-BR-3, a human breast, adenocarcinoma (pleural effusion) cell line; The cells were grown in McCoy's 5a Medium+10% FBS. To run the assay, the cells (80 ul, 1000 cells) were added to each well in a 96-well plate and incubated for 24 hours at 37°C. with CO,. Next, the cells were treated with test compounds (20 ul) at various concentrations in appropriate cell culture medium (total volume, 0.1 mL). The control wells contain cells and the medium but lack the test compounds. The plates were incubated for 144 hours at 37°C. with CO,. CTG reagent was then added to the wells (100 il). After the plates were shaken for 10 min and then incubated for 10 min at room temperature, paste the clear bottom with white back seal and record luminescence with Envision. The inhibition % was calculated according to the following equation: inhibition %=[1- (assay-blank)/ (control-blank)|x100.

   Click to Show/Hide
In Vitro Model Breast adenocarcinoma SK-BR-3 cells CVCL_0033
FeID1- (AL7-LP9)n [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
33.1 nM
Low ID1 expression (ID1+)
Method Description
The cell line used in the anti-proliferation assays was SK-BR-3, a human breast, adenocarcinoma (pleural effusion) cell line; The cells were grown in McCoy's 5a Medium+10% FBS. To run the assay, the cells (80 ul, 1000 cells) were added to each well in a 96-well plate and incubated for 24 hours at 37°C. with CO,. Next, the cells were treated with test compounds (20 ul) at various concentrations in appropriate cell culture medium (total volume, 0.1 mL). The control wells contain cells and the medium but lack the test compounds. The plates were incubated for 144 hours at 37°C. with CO,. CTG reagent was then added to the wells (100 il). After the plates were shaken for 10 min and then incubated for 10 min at room temperature, paste the clear bottom with white back seal and record luminescence with Envision. The inhibition % was calculated according to the following equation: inhibition %=[1- (assay-blank)/ (control-blank)|x100.

   Click to Show/Hide
In Vitro Model Breast adenocarcinoma SK-BR-3 cells CVCL_0033
References
Ref 1 Prodrugs of topoisomerase I inhibitor for ADC conjugations and methods of use thereof